Thu, Jul 10, 2014, 8:02 AM EDT - U.S. Markets open in 1 hr 28 mins


% | $
Quotes you view appear here for quick access.

Optimer Pharmaceuticals, Inc. (OPTR) Message Board

  • francolaval francolaval Jan 8, 2013 8:46 AM Flag

    Take-over target, finally?*
    Something needs to be done. This will be a $100 M sales company in 2013. They do need a second product and expand on current label, but, Cubist? Bayer? can look at this in 2013 and snap it up.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Regarding Cubist ... the $2.8 billion company, with at least three new therapies in the pipeline, still will need to use its $897 million in cash to buy a drugmaker such as Optimer Pharmaceuticals Inc. or Cadence Pharmaceuticals Inc., said Robert W. Baird & Co. A takeover of either would top Cubist’s largest deals for Calixa Therapeutics Inc. and Adolor Corp., data compiled by Bloomberg show. Cantor Fitzgerald LP says it also could look to smaller targets Trius Therapeutics Inc. or Cempra Inc. to add to its antibiotics portfolio.

12.780.00(0.00%)Oct 23 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.